Drawing for CGT

USPTO serial 79164279

CGT

Reviewed by CopyMark Law Group

Reg. 4920134Status 404
Filing date
Status date
Registration date
Mar 22, 2016
Examiner
BENMAMAN, ALICE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CGT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey H. Handelsman

Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.1950 Roland Clarke PlaceReston, VA 20191-1411UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Biological analysis; biochemical analysis; laboratory analysis in the field of reproductive genetics and infertility; consultancy relating to biotechnology; clinical testing services; clinical studies being medical and scientific research information in the field of clinical trials; biological research, clinical research and medical research; genetic research; scientific research relating to medicine particularly to reproductive medicine; conducting clinical trials for others; test method development services for prenatal testing as an alternative to amniocentesis, sperm testing and embryotic disease testingSECTION 71 - CANCELLED—
044Genetic analysis for medical treatment; medical advice, and particularly with regard to human infertility treatment; medical assistance; medical clinics; genetic testing for medical purposes; medical services for the treatment of infertility by means of assisted reproduction techniques; advisory services relating to medical problems; human fertility treatment services; advisory services relating to the treatment of degenerative diseasesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 11, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jul 11, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 11, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 31, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 11, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 11, 2023INPCINVALIDATION PROCESSED—
Jun 7, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 7, 2022C71TCANCELLED SECTION 71—
Mar 22, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 10, 2020CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Apr 22, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 22, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 22, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Apr 22, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 22, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 22, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 29, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 12, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 12, 2016FIMPFINAL DISPOSITION PROCESSED—
Jun 22, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 22, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 5, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 5, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 4, 2016GPNXNOTIFICATION PROCESSED BY IB—
Dec 16, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 16, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 16, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 2, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 25, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 25, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 25, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 18, 2015ALIEASSIGNED TO LIE—
Nov 5, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 30, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 30, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 22, 2015RFNTREFUSAL PROCESSED BY IB—
May 6, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 6, 2015RFRRREFUSAL PROCESSED BY MPU—
May 6, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
May 5, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 4, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 2, 2015DOCKASSIGNED TO EXAMINER—
May 2, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 30, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance